Oral low dose Amiodarone and prevention of atrial fibrillatio
Phase 2
- Conditions
- Coronary Artery Diseases.Atherosclerotic heart disease
- Registration Number
- IRCT201207303799N4
- Lead Sponsor
- Tehran University of Medical Sciences Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Patients with coronary artery disease (on angiography) who are candidate for coronary artery bypass. Exclusion criteria: 1- Patients above 80 years old. 2- Patients who have atrial fibrillation before surgery. 3- Patients with heart valve disease or arrhythmia or having every degree of heart block conduction. 4- Patients who use a pacemaker. 5- Patients who have chronic lung, liver or kidney disease. 6- Patients who have other heart surgeries simultaneously with bypass surgery. 7- Patients who are allergic to amiodarone or in any way giving amiodarone to them is contraindicated. 8- Having sick sinus syndrome.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AF rhythm. Timepoint: From the second day of the intervention and after CABG surgery, continuous monitoring for the first 72 hours and then daily ECG is done until discharge. Method of measurement: ECG recording device.;Length of stay in ICU. Timepoint: At the time of transferring to the ward. Method of measurement: Refer to the data sheet in ICU.;Duration of hospital stay. Timepoint: At discharge time. Method of measurement: Refer to the Patient file.
- Secondary Outcome Measures
Name Time Method